Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bhanot

Showing results (621-630 of 747) with videos related to

Pageof 75
Sort By:
Diabetes Care|June 9, 2016
Antisense-Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 DiabetesAndres Digenio, Richard L Dunbar, Veronica J Alexander, et al.
Endocrinology|October 28, 2006
Deficiency of adiponectin receptor 2 reduces diet-induced insulin resistance but promotes type 2 diabetesYanfang Liu, M Dodson Michael, Shera Kash, et al.
Diabetes|June 29, 2006
Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin actionVarman T Samuel, Cheol Soo Choi, Trevor G Phillips, et al.
Communications Biology|August 18, 2022
Subtype and cell type specific expression of lncRNAs provide insight into breast cancerSunniva Stordal Bjørklund, Miriam Ragle Aure, Jari Häkkinen, et al.
The Journal of Biological Chemistry|March 14, 2007
Reduction of low molecular weight protein-tyrosine phosphatase expression improves hyperglycemia and insulin sensitivity in obese miceSanjay K Pandey, Xing Xian Yu, Lynnetta M Watts, et al.
Nature Communications|June 18, 2026
L1CAM signaling through planar cell polarity drives SOX2 expression and lung adenocarcinoma metastasisJin Suk Park, Yasemin Kaygusuz, Carson Kenum, et al.
Diabetes Care|February 16, 2019
Antisense Inhibition of Glucagon Receptor by IONIS-GCGR<sub>Rx</sub> Improves Type 2 Diabetes Without Increase in Hepatic Glycogen Content in Patients With Type 2 Diabetes on Stable Metformin TherapyErin S Morgan, Li-Jung Tai, Nguyen C Pham, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2025
L1CAM signaling through planar cell polarity generates SOX2 <sup>+</sup> metastatic progenitors in lung adenocarcinomaJin Suk Park, Yasemin Kaygusuz, Carson Kenum, et al.
The Journal of Biological Chemistry|April 19, 2013
cAMP-responsive element-binding protein (CREB)-regulated transcription coactivator 2 (CRTC2) promotes glucagon clearance and hepatic amino acid catabolism to regulate glucose homeostasisDerek M Erion, Maya E Kotas, Jacob McGlashon, et al.
Immunity|March 23, 2021
Cytotoxic lymphocytes target characteristic biophysical vulnerabilities in cancerMaria Tello-Lafoz, Katja Srpan, Elisa E Sanchez, et al.
Pageof 75

Showing results (621-630 of 747) with videos related to

Sort By:
Pageof 75
Diabetes Care|June 9, 2016
Antisense-Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 DiabetesAndres Digenio, Richard L Dunbar, Veronica J Alexander, et al.
Endocrinology|October 28, 2006
Deficiency of adiponectin receptor 2 reduces diet-induced insulin resistance but promotes type 2 diabetesYanfang Liu, M Dodson Michael, Shera Kash, et al.
Diabetes|June 29, 2006
Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin actionVarman T Samuel, Cheol Soo Choi, Trevor G Phillips, et al.
Communications Biology|August 18, 2022
Subtype and cell type specific expression of lncRNAs provide insight into breast cancerSunniva Stordal Bjørklund, Miriam Ragle Aure, Jari Häkkinen, et al.
The Journal of Biological Chemistry|March 14, 2007
Reduction of low molecular weight protein-tyrosine phosphatase expression improves hyperglycemia and insulin sensitivity in obese miceSanjay K Pandey, Xing Xian Yu, Lynnetta M Watts, et al.
Nature Communications|June 18, 2026
L1CAM signaling through planar cell polarity drives SOX2 expression and lung adenocarcinoma metastasisJin Suk Park, Yasemin Kaygusuz, Carson Kenum, et al.
Diabetes Care|February 16, 2019
Antisense Inhibition of Glucagon Receptor by IONIS-GCGR<sub>Rx</sub> Improves Type 2 Diabetes Without Increase in Hepatic Glycogen Content in Patients With Type 2 Diabetes on Stable Metformin TherapyErin S Morgan, Li-Jung Tai, Nguyen C Pham, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2025
L1CAM signaling through planar cell polarity generates SOX2 <sup>+</sup> metastatic progenitors in lung adenocarcinomaJin Suk Park, Yasemin Kaygusuz, Carson Kenum, et al.
The Journal of Biological Chemistry|April 19, 2013
cAMP-responsive element-binding protein (CREB)-regulated transcription coactivator 2 (CRTC2) promotes glucagon clearance and hepatic amino acid catabolism to regulate glucose homeostasisDerek M Erion, Maya E Kotas, Jacob McGlashon, et al.
Immunity|March 23, 2021
Cytotoxic lymphocytes target characteristic biophysical vulnerabilities in cancerMaria Tello-Lafoz, Katja Srpan, Elisa E Sanchez, et al.
Pageof 75